Catalogo Articoli (Spogli Riviste)

OPAC HELP

Titolo:
Clinical correlates of estrogen replacement therapy use and duration of use among medicaid recipients
Autore:
Weiss, SR; Zuckerman, IH; Huang, XY; Hsu, VD;
Indirizzi:
Univ Maryland, Sch Pharm, Ctr Drugs & Publ Policy, Baltimore, MD 21201 USAUniv Maryland Baltimore MD USA 21201 Publ Policy, Baltimore, MD 21201 USA
Titolo Testata:
JOURNAL OF WOMENS HEALTH & GENDER-BASED MEDICINE
fascicolo: 8, volume: 10, anno: 2001,
pagine: 811 - 819
SICI:
1524-6094(200110)10:8<811:CCOERT>2.0.ZU;2-P
Fonte:
ISI
Lingua:
ENG
Soggetto:
BREAST-CANCER RISK; POSTMENOPAUSAL WOMEN; HORMONE-THERAPY; PLUS PROGESTIN; HEART-DISEASE; PREVENTION; BONE; DETERMINANTS; PREVALENCE; FRACTURES;
Tipo documento:
Article
Natura:
Periodico
Settore Disciplinare:
Social & Behavioral Sciences
Clinical Medicine
Citazioni:
36
Recensione:
Indirizzi per estratti:
Indirizzo: Weiss, SR Univ Maryland, Sch Pharm, Ctr Drugs & Publ Policy, 100 N Greene St,6th Floor, Baltimore, MD 21201 USA Univ Maryland 100 N Greene St,6th Floor Baltimore MD USA 21201 A
Citazione:
S.R. Weiss et al., "Clinical correlates of estrogen replacement therapy use and duration of use among medicaid recipients", J WOMEN H G, 10(8), 2001, pp. 811-819

Abstract

Estrogen replacement therapy (ERT) is used not only for the short-term control of menopausal symptoms but long-term for disease prevention. This study examined the influence of selected clinical conditions on the use of ERT and the duration of ERT use among women enrolled in a state Medicaid program. We identified 60,531 women, aged greater than or equal to 45 years, who were enrolled in Maryland Medicaid continuously for at least 2 of 3 years. ERT use was determined through prescription claims submitted for reimbursement. The presence or risk of selected clinical conditions (e.g., osteoporosis, heart disease, estrogen-sensitive cancers) was determined by screening Medicaid claims files for related diagnoses, procedures, or prescription claims. Multiple logistic regression was used to model ERT use, and proportional hazards regression was used to model duration of use. Fourteen percent of these women filled an ERT prescription, with use varying by age, race, and place of residence. Oral dosage forms were the most popular (80.8%), followed by vaginal cream or ring (22.2%), and transdermal patch (7.3%). In adjusted models, osteoporosis, heart disease, hypertension, hyperlipidemia, diabetes, ovarian cancer, and thromboembolic disease were positively associated and dementia and breast cancer were negatively associated with ERT use. None of these medical conditions predicted the duration of estrogen therapy. Use of ERT was very low among these women despite coverage of prescription medications, and the presence of clinical indications had no influence on the length of therapy among these women despite known benefits for long-term preventive therapy.

ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 15/07/20 alle ore 04:33:23